71 related articles for article (PubMed ID: 2851236)
1. [Characterization of opioid receptor from bullfrog brain].
Makimura M; Ito Y; Murakoshi Y
Yakubutsu Seishin Kodo; 1988 Jun; 8(2):359-66. PubMed ID: 2851236
[TBL] [Abstract][Full Text] [Related]
2. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
3. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of NaCl and guanyl-5'yl-imidodiphosphate (GppNHp) on [3H]naloxone binding to kappa-opioid receptors in guinea pig cerebellum.
Ishige K; Makimura M; Ito Y; Murakoshi Y
Biol Pharm Bull; 1993 Sep; 16(9):921-5. PubMed ID: 8268860
[TBL] [Abstract][Full Text] [Related]
5. Some properties of brain opioid receptors in membrane bound and solubilized state.
Ito Y; Makimura M; Murakoshi Y
Neuropeptides; 1984 Dec; 5(1-3):193-6. PubMed ID: 6099495
[TBL] [Abstract][Full Text] [Related]
6. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
7. Anatomical distribution of sodium-dependent [(3)H]naloxone binding sites in rat brain.
Sim-Selley LJ; Xiao R; Childers SR
Synapse; 2000 Mar; 35(4):256-64. PubMed ID: 10657035
[TBL] [Abstract][Full Text] [Related]
8. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
Ensinger HA
Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
[TBL] [Abstract][Full Text] [Related]
9. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
Garzón J; Sánchez-Blázquez P; Lee NM
J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
[TBL] [Abstract][Full Text] [Related]
10. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
Tam SW; Liu-Chen LY
J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
[TBL] [Abstract][Full Text] [Related]
11. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5'-yl imidodiphosphate.
Wong CS; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1994 Feb; 268(2):653-61. PubMed ID: 8113975
[TBL] [Abstract][Full Text] [Related]
12. Modulation of rat brain opioid receptors by cannabinoids.
Vaysse PJ; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
[TBL] [Abstract][Full Text] [Related]
13. Effect of N-ethylmaleimide treatment on naloxone binding in frog brain membranes.
Zawilska J; Lajtha A; Borsodi A
Acta Biochim Biophys Hung; 1989; 24(1-2):33-9. PubMed ID: 2575315
[TBL] [Abstract][Full Text] [Related]
14. Interaction of opiate receptor binding sites and guanine nucleotide regulatory sites: selective protection from N-ethylmaleimide.
Childers SR
J Pharmacol Exp Ther; 1984 Sep; 230(3):684-91. PubMed ID: 6088761
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptors in porcine caudate nucleus. II. Different effects of N-ethylmaleimide on [3H]cis-methyldioxolane binding to heat-labile (guanyl nucleotide-sensitive) sites and heat-stable (guanyl nucleotide-insensitive) sites.
Nukada T; Haga T; Ichiyama A
Mol Pharmacol; 1983 Nov; 24(3):374-9. PubMed ID: 6633504
[TBL] [Abstract][Full Text] [Related]
16. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
17. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
18. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
[TBL] [Abstract][Full Text] [Related]
19. Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain.
Nock B; Giordano AL; Moore BW; Cicero TJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):349-59. PubMed ID: 8380865
[TBL] [Abstract][Full Text] [Related]
20. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors.
Oktem HA; Apaydin S
Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
